FindTrial
Sign In

Holo Heart Tablets for Better Heart Health A Study in People with High Cholesterol

A Clinical study to evaluate the efficacy of Holo Heart in the patient of hyperlipidemia as a preventive therapy to improves cardiovascular health - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097620
Enrollment
50
Registered
2025-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E784- Other hyperlipidemia Health Condition 2: E784- Other hyperlipidemia

Interventions

None listed

Sponsors

ZEROHARM Science Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects suffering with hyperlipidemia Subjects not suffering from any significant illness (medical / surgical)

Exclusion criteria

Exclusion criteria: Subjects below 18 years or above 70 years of age. Associated with any other serious systemic disease or complication, which leads to fatal conditions.

Design outcomes

Primary

MeasureTime frame
Result will be assessed on the basis of Lipid profile reports, ECG and sign and symptoms of Sthoulyadone before and after the treatment. Investigations: Lipid profile, Blood routine, ECG, Blood pressure, Homocystine levels.Timepoint: 3 months—

Secondary

MeasureTime frame
Outcome TimePoints ASSESSMENT CRITERIA: As per thesis registered under ARD of JamanagarUniversity work satisfactorily ,Excess perspiration, Heaviness, Exertional Dyspnoea, Excess thirst, Excess hunger.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr Anup Baishya

Govt Ayurvedic College Hospital

baishya.anup.815@gmail.com8638211711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026